University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 0C-09-3


 
Description: A Phase I, Multi-Arm, Dose Escalation Study of Brivanib Alaninate Combined with Several Chemotherapy Regimens in Subjects with Advanced or Metastatic Solid Tumors.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Anthony El-KhoueiryM.D.

Data Management
NameTitle
Claire HughlettR.N.
Mary OrdazD.M.
Anayansi MiloudD.M.
Xiomara MenendezR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.